Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial

Department of General Practice, Institute for Research in Extramural Medicine, VU Medical Centre, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
The British journal of psychiatry: the journal of mental science (Impact Factor: 7.34). 04/2010; 196(4):319-25. DOI: 10.1192/bjp.bp.109.069617
Source: PubMed

ABSTRACT There is an urgent need for the development of cost-effective preventive strategies to reduce the onset of mental disorders.
To establish the cost-effectiveness of a stepped care preventive intervention for depression and anxiety disorders in older people at high risk of these conditions, compared with routine primary care.
An economic evaluation was conducted alongside a pragmatic randomised controlled trial (ISRCTN26474556). Consenting individuals presenting with subthreshold levels of depressive or anxiety symptoms were randomly assigned to a preventive stepped care programme (n = 86) or to routine primary care (n = 84).
The intervention was successful in halving the incidence rate of depression and anxiety at euro563 ( pound412) per recipient and euro4367 ( pound3196) per disorder-free year gained, compared with routine primary care. The latter would represent good value for money if the willingness to pay for a disorder-free year is at least euro5000.
The prevention programme generated depression- and anxiety-free survival years in the older population at affordable cost.

Download full-text


Available from: Harm Van Marwijk, Jan 20, 2014
  • Journal of the American College of Surgeons 05/2004; 198(4):645-52. DOI:10.1016/j.jamcollsurg.2003.11.015 · 4.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Achieving remission in late-life depressive disorder is difficult; it is far better to prevent depression. In the last ten years there have been a number of clinical studies of the feasibility of prevention. A limited literature review was undertaken of studies from 2000 specifically concerning the primary prevention of late-life depressive disorder or where primary prevention is a relevant secondary outcome. Selective primary prevention (targeting individuals at risk but not expressing depression) has been shown to be effective for stroke and macular degeneration but not hip fracture. It may also prove effective for the depression associated with caregiving in dementia. Emerging evidence finds effectiveness for indicated prevention (in those identified with subthreshold depression often with other risk factors such as functional limitation). Despite a number of promising risk factors (for example, diet, exercise, vascular risk factors, homocysteine and insomnia), universal prevention of late-life depression (acting to reduce the impact of risk factors at the population level) has no current evidence base, although a population approach might mitigate suicide. Interventions which work in preventing late-life depression include antidepressant medication in standard doses and Problem-Solving Treatment. When integrated into a care model, such as collaborative care, prevention is feasible but more economic studies are needed.
    International Psychogeriatrics 12/2010; 22(8):1216-24. DOI:10.1017/S1041610210000864 · 1.89 Impact Factor
  • The Lancet 12/2010; 376(9758):2045-6. DOI:10.1016/S0140-6736(10)61886-7 · 45.22 Impact Factor